Can We Reprogram Aging? Epigenetics, Cell Identity & the Future of Rejuvenation | Dr. Jose Polo

ReProgram Episode 24: Can We Reprogram Aging? Epigenetics, Cell Identity & the Future of Rejuvenation | Dr. Jose Polo 🎬 *EPISODE OVERVIEW* Every cell in your body contains essentially the same DNA, yet a neuron behaves nothing like a skin cell. So what actually gives a cell its identity — and how permanent is that identity? In this episode, Dr. George Murphy sits down with epigenetics and cellular reprogramming expert Dr. Jose Polo to explore how cells establish identity, how that identity can be rewritten, and what reprogramming really means for aging and rejuvenation. They discuss why cellular reprogramming is not the same thing as rejuvenation, Jose’s concept of “cell elasticity,” the danger of pushing a cell so far that it loses its identity, and the possibility of using targeted cell conversion as regenerative medicine. 👤 *ABOUT THE GUEST* Dr. Jose M. Polo is Director of the Adelaide Centre for Epigenetics in Australia. His research focuses on the transcriptional and epigenetic mechanisms that govern cell identity, pluripotency, cellular reprogramming, early development, and cancer. His laboratory has helped define the molecular sequence of somatic-cell reprogramming, developed strategies for direct cell-fate conversion, and pioneered human iBlastoid models of early embryonic development. Official profile: https://researchers.adelaide.edu.au/profile/jose.polo 🔑 *KEYWORDS* Epigenetics • Cellular Reprogramming • Cell Identity • Rejuvenation • Partial Reprogramming • Yamanaka Factors • Induced Pluripotent Stem Cells • Cell Elasticity • Epigenetic Clocks • Regenerative Medicine • iBlastoids • Human Embryo Models • Longevity • Aging 📌 *KEY TAKEAWAYS* • Cell identity is regulatory, not genetic. The same genome can produce radically different cell states depending on which programs are active. • Reprogramming is not the same as rejuvenation. Resetting cellular state may erase age-associated features, but that does not automatically mean restored function. • “Cell elasticity” may define the safe window for partial reprogramming. A cell can move away from its identity and return — until it crosses a point where that identity may no longer be recoverable. • Preserving identity is a central safety challenge. A cell that looks younger but loses its specialized function is not a successful rejuvenation strategy. • Cell-fate control could become medicine. Targeted reprogramming may one day convert resident cells into the cell types needed to repair damaged tissues. • iBlastoids demonstrate extraordinary human cell plasticity. But they are experimental models — not embryos — and their biological limits matter. 🎙️ *THE REPROGRAM PERSPECTIVE* Cellular reprogramming proves that cellular state is not fixed. But making an epigenetic clock move backward is not the same as making a cell healthier. The real goal of rejuvenation should be to restore function and resilience while preserving cell identity, tissue organization, and safety. In longevity science, the most meaningful endpoint is not simply whether a cell looks younger molecularly, but whether it behaves better biologically. ⏱️ *CHAPTERS* 02:27 Meet Dr. Jose Polo 05:34 What Makes a Cell a Neuron, Skin Cell, or Something Else? 08:15 What Is the Epigenome? 09:43 Reprogramming Is Not the Same as Rejuvenation 11:37 Does Epigenetic Change Cause Aging? 13:16 Cell Elasticity: How Far Can Identity Be Pushed? 14:39 The Danger Zone: Losing Cell Identity 16:48 Reprogramming Cells as Medicine 19:20 How Adult Cells Became Human Embryo Models 22:21 iBlastoids: What They Are — and What They Are Not 23:54 Is Aging a Failure of Cell Identity? 25:27 Can We Erase Bad Epigenetic Memory? 27:07 What We Still Do Not Understand About Reprogramming 📝 *NOTES AND REFERENCES* 1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126(4):663-676. PMID: 16904174. https://pubmed.ncbi.nlm.nih.gov/16904174/ 2. Polo JM, Anderssen E, Walsh RM, et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell. 2012;151(7):1617-1632. PMID: 23260147. https://pubmed.ncbi.nlm.nih.gov/23260147/ 3. Ocampo A, Reddy P, Martinez-Redondo P, et al. In Vivo Amelioration of Age-Associated Hallmarks by Partial Reprogramming. Cell. 2016;167(7):1719-1733.e12. PMID: 27984723. https://pubmed.ncbi.nlm.nih.gov/27984723/ 4. Liu X, Tan JP, Schroder J, et al. Modelling human blastocysts by reprogramming fibroblasts into iBlastoids. Nature. 2021;591:627-632. https://doi.org/10.1038/s41586-021-03372-y 5. Nunez JK, Chen J, Pommier GC, et al. Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing. Cell. 2021;184(9):2503-2519.e17. PMID: 33838111. https://pubmed.ncbi.nlm.nih.gov/33838111/ *If you value longevity science without the hype, subscribe to The ReProgram. Mechanism over marketing. Evidence over anecdotes. Trade-offs over hype.*